Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Greenlight Capital Re Signals Momentum After Strong 2025

Tipranks - Wed Mar 11, 7:14PM CDT

Greenlight Capital Re ((GLRE)) has held its Q4 earnings call. Read on for the main highlights of the call.

Claim 70% Off TipRanks Premium

Greenlight Capital Re closed 2025 on a strong note, with management striking an upbeat tone despite emerging headwinds. Executives highlighted record underwriting income, solid net income, double‑digit book‑value growth, and a strengthened balance sheet, aided by an AM Best upgrade and aggressive deleveraging. They acknowledged softer reinsurance pricing, elevated expenses, and isolated large losses, but emphasized that core profitability and capital management are moving firmly in the right direction.

Robust Q4 Earnings and Improved Underwriting

Q4 2025 net income reached $49.3 million, or $1.44 per diluted share, powered by a net underwriting profit of $13.0 million and a 92.1% combined ratio. That marked an improvement of roughly 10 points versus the prior year after adjusting for Russia‑Ukraine reserve actions, signaling healthier underwriting fundamentals across the portfolio.

Strong but Mixed Investment Performance from Solasglas

The Solasglas investment portfolio contributed meaningfully, generating a 7.9% return in Q4 and $36.2 million of investment income for the quarter alone. For full‑year 2025 the strategy returned 7.5%, and it has started 2026 even stronger with a 9.8% gain through February, though management noted it lagged the S&P 500 last year and some specific holdings detracted in Q4.

Record Full‑Year Profitability Metrics

For 2025, Greenlight Capital Re reported record underwriting income of $35.7 million alongside a full‑year combined ratio of 94.6%. Net income for the year totaled $74.8 million, or $2.17 per diluted share, underscoring how both underwriting and investments are now contributing more consistently to the bottom line.

Book Value Momentum Accelerates

Fully diluted book value per share rose 13.8% in 2025 to $20.43, reflecting both earnings growth and disciplined capital deployment. Over the past three years, fully diluted book value per share has climbed 42.6%, or about 12.5% annualized, a key metric for investors focused on long‑term intrinsic value compounding.

Premium Growth and Scaling of Innovations Segment

Open Market net written premiums advanced 9% to $123.6 million, with net earned premiums up 11%, showing healthy growth in core business. The Innovation segment expanded even faster, with Q4 gross written premiums jumping 80% to $37.1 million and full‑year gross written premiums rising 28% to $121.6 million, making up 16% of total premiums as Greenlight builds diversified specialty platforms.

Open Market Segment Delivers Big Underwriting Turnaround

The Open Market book posted a Q4 combined ratio of 90.7%, an improvement of about 20.4 points year over year, highlighting successful risk selection and pricing. That drove pretax income of $28.2 million for the quarter, including $13.2 million of underwriting income and $15.0 million of investment income, making the segment a key profit engine.

Balance Sheet Deleveraging and Shareholder Returns

Management continued to tighten the capital structure by repaying $30 million of debt in Q4, leaving just $5 million outstanding and cutting the leverage ratio from 9.5% to 0.7%. The company also repurchased 201,000 shares for $2.8 million in the quarter and $9.8 million for all of 2025 at an average price of $13.76, with $20.2 million of buyback authorization still available for opportunistic repurchases.

Rating Upgrade and Capital Strength Recognized

AM Best upgraded Greenlight Capital Re’s rating from A‑ to A in November, a milestone the company linked to its stronger capitalization and reduced leverage. Management underscored that 2025 featured the highest premium levels in the firm’s history, achieved while simultaneously fortifying the balance sheet, which should support future business growth and investor confidence.

Renewal Wins and Lloyd’s Syndicate Expansion

At the crucial 1/1 renewals, the Funds at Lloyd’s book increased about 21%, evidencing strong demand and retention. Specialty premiums grew 6%, Innovations premiums at 1/1 surged roughly 83%, and the Outwards Innovations whole account quota share was renewed with the cession lifted from 28% to 33%, while Syndicate 3456 welcomed third‑party capital for the first time, expanding its platform reach.

Innovations Segment Profitability Pressured by Loss and Expenses

Despite impressive top‑line growth, the Innovations segment’s Q4 combined ratio was 101.7%, producing a modest $0.4 million underwriting loss. The shortfall was driven largely by a $2.1 million surety loss and a higher expense ratio of 9.5% versus 3.3% a year earlier as the company invests in scaling the business and pays higher incentive compensation.

Impact of Large Losses and Reserve Strengthening

Quarterly results included several notable events, including a $2.0 million loss from Hurricane Melissa and a $2.7 million loss tied to an oil refinery fire. In addition, the company strengthened prior‑year reserves by $5.5 million, mainly on casualty programs in runoff, which partially dampened otherwise strong underwriting improvements but was framed as conservative risk management.

Softening Market Conditions and Rising Cat Exposure

Management flagged meaningful price pressure at the 1/1 renewals, with Specialty rates down about 11% and Property rates down around 12%. Property exposure overall remained roughly flat, but with weaker pricing the firm’s modeled North Atlantic 1‑in‑250 hurricane loss increased 7% to $139 million, underscoring the need for continued pricing discipline and risk selection.

Relative Underperformance of Solasglas vs. Index

While Solasglas delivered solid absolute gains, its 7.5% return in 2025 trailed the S&P 500’s 17.9%, reflecting relative underperformance versus a strong equity benchmark. Management pointed to specific detractors in Q4, including weakness in names such as Green Brick and Penn, as well as inflation swaps, while maintaining confidence in the strategy’s long‑term value‑oriented approach.

Rising Expense Ratios Weigh on Near‑Term Margins

The overall quarterly expense ratio increased by 1.8 points, driven mainly by performance‑based compensation tied to improved results. Within the Innovation segment, expenses rose more sharply as Greenlight invests to scale these businesses, a trend management acknowledged will pressure near‑term profitability but is expected to ease once growth initiatives mature.

Monitoring Geopolitical Exposures

Executives also addressed geopolitical risk, particularly rising tensions in the Middle East, noting that notified insured losses remain limited so far. However, the company does have exposure through marine, aviation, and war‑on‑land covers and is actively monitoring the evolving situation, reflecting a cautious stance amid a fluid global risk backdrop.

Forward‑Looking Outlook and Capital Deployment Plans

Looking ahead to 2026, management expressed confidence that the business can build on its 2025 momentum while remaining disciplined in a softening market. They highlighted the ongoing deployment of a $100 million fixed‑maturity allocation, continued share repurchases and reduced leverage, expectations that Innovation segment expenses will normalize over 18–24 months, and a more balanced Solasglas risk profile, all while keeping a close eye on market and geopolitical risks.

Greenlight Capital Re’s latest call painted a picture of a company transitioning from recovery to sustained value creation, with underwriting, investments, and capital management now working in concert. Investors will be watching how management navigates softening rates, elevated expenses, and geopolitical uncertainty, but for now the trajectory in earnings, book value, and balance‑sheet strength appears firmly positive.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.